CLMT

$28.63

Market ClosedAs of Mar 17, 8:00 PM UTC

Calumet, Inc.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$28.63
Potential Upside
5%
Whystock Fair Value$30.06
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorBasic Materials
IndustrySpecialty Chemicals

Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segme...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.48B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.04
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.42

Recent News

Simply Wall St.
Mar 8, 2026

Assessing Calumet (CLMT) Valuation After Strong Multi‑Period Share Price Gains

Why Calumet Has Caught Investor Attention Calumet (CLMT) has come into focus after a period of strong share price moves, with gains over the past month, past 3 months, year to date, and past year prompting investors to reassess the story. See our latest analysis for Calumet. Recent trading has been strong, with a 20.68% 1 month share price return and a 56.78% 3 month share price return, while the 1 year total shareholder return of 153.97% and 5 year total shareholder return of around 5x...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Mar 2, 2026

Here’s Why Crossroads Capital Sold Its Stake in Calumet (CLMT)

Crossroads Capital LLC, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 2.7% net of fees and expenses in Q4 2025, bringing its annual return to 37.7% net. Since its inception, the Fund compounded at the rate of 21.2% gross and 17.1% net. […]

BEARISH
Negative press. News cycle fixated on risk factors or misses.
GuruFocus.com
Feb 27, 2026

Calumet Inc (CLMT) Q4 2025 Earnings Call Highlights: Strong EBITDA Growth Amidst Market Challenges

Calumet Inc (CLMT) reports a 30% increase in adjusted EBITDA, while navigating regulatory uncertainties and market headwinds.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Feb 27, 2026

Calumet, Inc. Q4 2025 Earnings Call Summary

Moby summary of Calumet, Inc.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
MarketBeat
Feb 27, 2026

Calumet Q4 Earnings Call Highlights

Calumet (NASDAQ:CLMT) executives used the company’s fourth-quarter and full-year fiscal 2025 earnings call to highlight what CEO Todd Borgmann described as a “defining high impact year,” pointing to improved profitability, lower leverage, and the closing of a U.S. Department of Energy (DOE) loan at

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.